SEC Form 4 · accession 0001140361-17-000833
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rami Elghandour
Officer — President & CEO · Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 3, 2017 | A | 31,044 | $0.00 | A | 95,224 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $75.17 | Jan 3, 2017 | A | 124,175 | A | — | Jan 2, 2027 | Common Stock | 124,175 | 124,175 | D |
Explanation of responses
- F1Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on January 3 of each year, beginning January 3, 2018, subject to the Reporting Person's continued service to the issuer.
- F2Includes 94,739 RSUs.
- F31/48th of the shares subject to the option vest on each monthly anniversary measured from January 3, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the issuer.